[Pneumococcal resistance to beta-lactams: implications for the treatment of acute otitis media].
Solignac
M
M
D000208:Acute Disease; D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use; D004739:England; D005602:France; D005858:Germany; D006192:Haemophilus Infections / Q000188:drug therapy; D006193:Haemophilus influenzae; D006801:Humans; D010033:Otitis Media / Q000188:drug therapy* / Q000382:microbiology; D010403:Penicillin Resistance; D011008:Pneumococcal Infections / Q000188:drug therapy*; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy; D013030:Spain; D013296:Streptococcus pneumoniae
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D000658:Amoxicillin
Résistance du pneumocoque aux bêta-lactamines: implications dans le traitement de l'otite moyenne aiguë.